Cargando…
Glycogen synthase kinase 3 beta: can it be a target for oral cancer
Despite progress in treatment approaches for oral cancer, there has been only modest improvement in patient outcomes in the past three decades. The frequent treatment failure is due to the failure to control tumor recurrence and metastasis. These failures suggest that new targets should be identifie...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906469/ https://www.ncbi.nlm.nih.gov/pubmed/20537194 http://dx.doi.org/10.1186/1476-4598-9-144 |